je.st
news
Why Did Merck Spend $4 Billion on a Tiny Biotech Firm?
2014-06-14 11:42:27| Biotech - Topix.net
Merck & Co. Inc. has had its sights set on conquering the hepatitis C market for a long time now, and the recovering drugmaker is hoping that a small Cambridge, Massachusetts-based biotech company, Idenix Pharmaceuticals, Inc. , can help it move forward in the race to develop a serious competitor to Gilead Sciences' blockbuster treatment, Sovaldi.
Tags: firm
spend
billion
tiny
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||